CA Patent
CA2933994A1 — Boron-containing small molecules as anti-inflammatory agents
Assigned to Anacor Pharmaceuticals LLC · Expires 2007-08-23 · 19y expired
What this patent protects
Methods of treating anti-inflammatory conditions through the use of boron-containing small molecules are disclosed.
USPTO Abstract
Methods of treating anti-inflammatory conditions through the use of boron-containing small molecules are disclosed.
Drugs covered by this patent
- Eucrisa (Crisaborole) · Anacor Pharms Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.